市场调查报告书
商品编码
1603302
医用塑胶市场规模、份额、成长分析,按类型、应用、工艺、地区划分 - 产业预测,2024-2031 年Medical Plastics Market Size, Share, Growth Analysis, By Type(Standard Plastics, Engineering Plastics, High Performance Plastic ), By Application, By Process, By Region - Industry Forecast 2024-2031 |
2022年全球医用塑胶市场规模估值为465亿美元,从2023年的501.3亿美元成长到2031年的985.5亿美元,预计在预测期内(2024-2031年)复合年增长率为7.8%。美元。
医用塑胶市场的特点是可以模製成各种形状的聚合物,例如聚碳酸酯、聚丙烯和聚乙烯,由于医疗保健投资的增加和消费者健康意识的提高,预计该市场将显着增长。医用聚合物独特的耐热和耐化学性能使其成为各种医疗设备和仪器(包括手术管)的理想材料。随着可支配收入的增加和消费者生活方式的发展,预计未来几年对医用塑胶的需求将会增强。 2022 年第一季季的医疗设备新增销售量最初因社交距离和封锁而下降,但COVID-19 大流行导致实验室外套、口罩和手套等一次性医疗产品的销售增加,刺激了对医疗器材的需求。个人防护设备(PPE)的一次性使用作为安全通讯协定已经激增,凸显了市场的适应性。儘管疫情带来挑战,但医用塑胶产业正在復苏,预计将稳步恢復势头,反映出该行业在市场动态变化中的韧性。总体而言,全球医用塑胶市场继续在新冠疫情后的格局中前行,同时利用消费者不断变化的健康优先事项,前景仍然乐观。
Global Medical Plastics Market size was valued at USD 46.5 billion in 2022 and is poised to grow from USD 50.13 billion in 2023 to USD 98.55 billion by 2031, growing at a CAGR of 7.8% in the forecast period (2024-2031).
The medical plastics market, characterized by polymers such as polycarbonate, polypropylene, and polyethylene that can be molded into diverse shapes, is set for significant growth driven by heightened investments in healthcare and increasing consumer health awareness. The inherent properties of medical-grade polymers, which are resistant to heat and chemicals, position them as ideal materials for a range of medical devices and equipment, including surgical tubing. As disposable incomes rise and consumer lifestyles evolve, demand for medical plastics is expected to intensify in the coming years. Notably, the COVID-19 pandemic spurred demand for disposable medical products, such as test gowns, masks, and gloves, despite an initial dip in new medical device sales during Q1 and Q2 of 2022 attributed to social distancing measures and lockdowns. The preference for single-use personal protective equipment (PPE) surged as a safety protocol, highlighting the adaptability of the market. Although the pandemic presented challenges, the medical plastics sector is rebounding and is expected to steadily regain momentum, reflecting the resilience of the industry amidst changing market dynamics. Overall, the outlook for the global medical plastics market remains positive as it continues to navigate the post-COVID landscape while leveraging evolving consumer health priorities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Medical Plastics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Medical Plastics Market Segmental Analysis
Global Medical Plastics Market is segmented by Type, by Product, by Application, by Process and by Region. Based on Type, the market is segmented into Standard Plastics, Engineering Plastics, High Performance Plastic (HPP), Silicone, and Others. Based on Application, the market is segmented into Medical disposables, Prosthetics, Medical Instruments & Tools, Drug Delivery, and Others. Based on Process, the market is segmented Extrusion, Injection Molding, Blow Molding, Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
Driver of the Global Medical Plastics Market
The global Medical Plastics market is being significantly propelled by the increasing demand for recyclable medical plastics, driven largely by the expansion of the medical sector worldwide. The ongoing COVID-19 pandemic has led to a surge in the use of single-use medical plastics and consumables within healthcare facilities, necessitating items such as thermal scanners, ventilators, gloves, respirators, and masks in hospitals, clinics, and diagnostic centers. Additionally, innovations in medical polymers improving biocompatibility are enhancing cost-effectiveness and enabling advancements in targeted drug delivery systems. Furthermore, the rapid development of healthcare infrastructure in emerging markets, coupled with a growing elderly population, is expected to further stimulate market growth.
Restraints in the Global Medical Plastics Market
The Global Medical Plastics market faces significant restraints due to growing concerns about environmental sustainability. The surge in population results in heightened demand for plastic products, which in turn leads to increased plastic production and waste, contributing to environmental pollution. Many medical plastics are non-recyclable and are often discarded individually to manage infection control, complicating waste management efforts. This situation has intensified issues like soil and water degradation. Additionally, the COVID-19 pandemic has escalated plastic use, further straining the environment. Consequently, stringent environmental regulations may adversely impact the demand for medical plastics and stifle industry growth.
Market Trends of the Global Medical Plastics Market
The Global Medical Plastics market is witnessing a notable trend of price volatility driven by fluctuating oil prices, which significantly influences the costs of key polymers such as Polyvinyl Chloride (PVC), Polyethylene (PE), Polypropylene (PP), and Polystyrene (PS). This instability is further compounded by shifts in industry capacity expansions and reductions, particularly in response to demand fluctuations. Additionally, overproduction in the Chinese market is anticipated to exert pressure on raw material prices, creating further uncertainty in the market. Amidst this, companies are adapting strategies to stabilize supply chains, highlighting an ongoing struggle between maintaining market stability and navigating price uncertainties.